Search Results - "Clézardin, P."
-
1
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
Published in Annals of oncology (01-03-2016)“…Bisphosphonates have been studied in randomised trials in early breast cancer to investigate their ability to prevent cancer treatment-induced bone loss…”
Get full text
Journal Article -
2
Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs
Published in Oncogene (07-02-2013)“…Little is known about metastatic pathways that are specific to the lung rather than other organs. We previously showed that antioxidant proteins such as…”
Get full text
Journal Article -
3
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
Published in Clinical & translational oncology (01-08-2019)“…Drug repurposing offers advantages over traditional drug development in terms of cost, speed and improved patient outcomes. The receptor activator of nuclear…”
Get full text
Journal Article -
4
Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo
Published in British journal of cancer (26-06-2012)“…Background: The small stress heat shock protein 27 (Hsp27) has recently turned as a promising target for cancer treatment. Hsp27 upregulation is associated…”
Get full text
Journal Article -
5
Increased Dickkopf-1 expression in breast cancer bone metastases
Published in British journal of cancer (08-10-2007)“…The aim of this study was to determine whether Dickkopf-1 (Dkk-1) expression in breast cancer was associated with bone metastases. We first analysed Dkk-1…”
Get full text
Journal Article -
6
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors
Published in Oncogene (01-02-2019)“…Bone is the most common metastatic site for breast cancer. Estrogen-related-receptor alpha (ERRα) has been implicated in cancer cell invasiveness. Here, we…”
Get full text
Journal Article -
7
RANK expression predicts long term outcome in early luminal breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
8
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
Published in Journal of bone oncology (01-08-2021)“…•Matrix protein periostin is involved in cancer cell dissemination and bone response.•Serum periostin level was higher in adenocarcinoma lung cancer patients…”
Get full text
Journal Article -
9
Influence of human cancer cell lines on mechanical properties of mice tibia
Published in Computer methods in biomechanics and biomedical engineering (19-10-2020)Get full text
Journal Article -
10
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis
Published in Calcified tissue international (01-11-2018)“…Periostin is an extracellular matrix protein that actively contributes to tumor progression and metastasis. Here, we hypothesized that it could be a marker of…”
Get full text
Journal Article -
11
Early Detection of Bone Metastases in a Murine Model Using Fluorescent Human Breast Cancer Cells: Application to the Use of the Bisphosphonate Zoledronic Acid in the Treatment of Osteolytic Lesions
Published in Journal of bone and mineral research (01-11-2001)“…A very common metastatic site for human breast cancer is bone. The traditional bone metastasis model requires human MDA‐MB‐231 breast carcinoma cell…”
Get full text
Journal Article -
12
Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells
Published in Cancer letters (01-02-2015)“…Highlights • PC-3 prostate cancer cells treated with zoledronate were shown to be resistant to Vγ9Vδ2 T cell cytotoxicity. • Resistance was attributed to the…”
Get full text
Journal Article -
13
The role of the calcium sensing receptor in the migration of breast cancer cells
Published in Bone (New York, N.Y.) (01-12-2012)Get full text
Journal Article -
14
Effect of lysophosphatidic acid (LPA) on osteoclastogenesis
Published in Bone (New York, N.Y.) (01-05-2009)Get full text
Journal Article -
15
Erratum to “Periostin as a circulating marker for breast cancer bone metastases” [Bone 47S2 (2010) S328–S329]
Published in Bone (New York, N.Y.) (01-03-2011)Get full text
Journal Article -
16
Integrins in bone metastasis formation and potential therapeutic implications
Published in Current cancer drug targets (01-11-2009)“…Integrins constitute a family of cell surface receptors that are heterodimers composed of noncovalently associated alpha and beta subunits. Integrins bind to…”
Get more information
Journal Article -
17
Twist 1 expression in an osteotropic breast cancer cell line promotes bone metastasis formation in mouse
Published in Bone (New York, N.Y.) (01-01-2011)Get full text
Journal Article -
18
-
19
Interaction of autotaxin with breast cancer cell integrins might contribute to lysophosphatidic acid-mediated bone metastases
Published in Bone (New York, N.Y.) (01-01-2011)Get full text
Journal Article -
20
Propriétés antitumorales du bisphosphonate zolédronate et implications thérapeutiques potentielles en clinique
Published in Bulletin du cancer (01-08-2010)“…Le zolédronate ainsi que les autres bisphosphonates inhibent la résorption osseuse en bloquant l'activité des ostéoclastes. C'est pour cette raison qu'ils sont…”
Get full text
Journal Article